We're buying more of this life sciences stock after an earnings-driven decline

The stock is under pressure in early trading due to uncertainty around the recovery in a key business.

KickT KickT
Oct 24, 2023 - 21:05
0 43
We're buying more of this life sciences stock after an earnings-driven decline

CNBC Investing Club

Published Tue, Oct 24 20239:27 AM EDTUpdated An Hour Ago